SMS Pharmaceuticals Ltd (SMSPHARMA):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:SMS Pharmaceuticals Ltd (SMSPHARMA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9821
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SMS Pharmaceuticals Ltd (SMS Pharma) is a manufacturer of active pharmaceutical ingredients (APIs) and intermediates that develops offers anti-fungal, anti-ulcer, anti-migraine, anti-hypersensitive, anti-psychotic, anti-viral and other products. Its pipeline products include Ticagrelor, Clopidogrel Bisulfate, Montelukast Sodium, Apixaban, Rivaroxaban, Gabapentin Enacarbil, Lamotrigine and Sofosbuvir among others. Its contract research includes study of synthetic feasibility, process development and scale up, selection of synthetic route and lead optimization and analogue synthesis. It has four manufacturing facilities namely Khazipally unit, Bachupally unit, Jeedimetla unit and Visakhapatnam unit. SMS Pharma is headquartered in Hyderabad, Telangana, India.

SMS Pharmaceuticals Ltd (SMSPHARMA) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SMS Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SMS Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SMS Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SMS Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SMS Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
SMS Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
SMS Pharma Plans to Form Joint Venture with Chemo 10
Equity Offering 11
VKT Pharma Raises USD1 Million in Private Placement of Shares 11
Asset Transactions 12
Mylan Labs To Acquire Manufacturing Unit Of SMS Pharma For US$33 Million 12
Acquisition 13
SMS Pharma To Invest Up To US$4.9 Million In VKT Pharma 13
SMS Pharmaceuticals Ltd – Key Competitors 14
SMS Pharmaceuticals Ltd – Key Employees 15
SMS Pharmaceuticals Ltd – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Corporate Communications 17
Jun 15, 2018: SMS Pharmaceuticals Announces Board Change 17
May 30, 2018: SMS Pharmaceuticals Appoints Mr. Shravan Kudaravalli As Additional Director 18
May 30, 2017: SMS Pharmaceuticals Announces Resignation of Mr. N. Rajendra Prasad as Chief Financial Officer 19
Legal and Regulatory 20
Jan 22, 2018: SMS Pharmaceuticals Receives Establishment Inspection Report from US FDA 20
Nov 18, 2017: SMS Pharmaceuticals has successfully completed, its Fifth US Food and Drug Administration (US FDA) inspection 21
Aug 23, 2017: SMS Pharmaceuticals updates on Pharmaceuticals and Medical Devices Agency inspection at manufacturing facility Unit4I, located at Bachupally 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
SMS Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
SMS Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SMS Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SMS Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SMS Pharmaceuticals Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
SMS Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
SMS Pharma Plans to Form Joint Venture with Chemo 10
VKT Pharma Raises USD1 Million in Private Placement of Shares 11
Mylan Labs To Acquire Manufacturing Unit Of SMS Pharma For US$33 Million 12
SMS Pharma To Invest Up To US$4.9 Million In VKT Pharma 13
SMS Pharmaceuticals Ltd, Key Competitors 14
SMS Pharmaceuticals Ltd, Key Employees 15
SMS Pharmaceuticals Ltd, Other Locations 16

List of Figures
SMS Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
SMS Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
SMS Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
SMS Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
SMS Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SMS Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
SMS Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SMS Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[SMS Pharmaceuticals Ltd (SMSPHARMA):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Enel Green Power SpA:企業の戦略的SWOT分析
    Enel Green Power SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • APR Energy Ltd:企業の戦略的SWOT分析
    APR Energy Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • GW Pharmaceuticals Plc (GWPH):医療機器:M&Aディール及び事業提携情報
    Summary GW Pharmaceuticals Plc (GW Pharmaceuticals) is a biopharmaceutical company that discovers, develops and commercializes novel therapeutics from its proprietary cannabinoid product platform. The company’s commercialized product, Sativex is a plant-derived cannabinoid prescription drug, for the …
  • Fertin Pharma AS:製薬・医療:M&Aディール及び事業提携情報
    Summary Fertin Pharma A/S (Fertin Pharma) is a pharmaceutical company that develops and manufactures medicated chewing gum. The company offers pharmaceutical chewing gum products for therapeutic areas such as allergy, cough and cold, nicotine replacement, gastrointestinal, pain and oral care, among …
  • GTT Communications Inc (GTT):企業の財務・戦略的SWOT分析
    GTT Communications Inc (GTT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Capsugel Inc-製薬・医療分野:企業M&A・提携分析
    Summary Capsugel Inc (Capsugel) is a contract manufacturing company which designs, develops and manufactures a range of innovative dosage forms. It provides contract services to the biopharmaceutical and consumer health and nutrition industries. The company’s services enable clients to enhance the b …
  • Kohinoor Energy Limited (KOHE):企業の財務・戦略的SWOT分析
    Kohinoor Energy Limited (KOHE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Vivimed Labs Ltd (VIVIMEDLAB):企業の財務・戦略的SWOT分析
    Vivimed Labs Ltd (VIVIMEDLAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Covalon Technologies Ltd (COV)-医療機器分野:企業M&A・提携分析
    Summary Covalon Technologies Ltd (Covalon) is a researcher, developer and commercialization of medical devices and healthcare technologies. The company offers advanced wound solutions, infection prevention products and perioperative care products. Covalon offers wound care products such as collagen …
  • Bullfrog Power Inc.:電力:M&Aディール及び事業提携情報
    Summary Bullfrog Power Inc. (Bullfrog Power) is a provider of green energy. It offers renewable energy solutions that help businesses and houses in reducing their environmental impact. Bullfrog's product portfolio includes green electricity, green fuel and green natural gas. The company, through its …
  • Sony Corp (6758):企業の財務・戦略的SWOT分析
    Sony Corp (6758) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • BOE Technology Group Co Ltd:戦略・SWOT・企業財務分析
    BOE Technology Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary BOE Technology Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Grupo Televisa, S.A.B. (TLEVISACPO):企業の財務・戦略的SWOT分析
    Grupo Televisa, S.A.B. (TLEVISACPO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Society for Worldwide Interbank Financial Telecommunication:企業の戦略的SWOT分析
    Society for Worldwide Interbank Financial Telecommunication - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, k …
  • Rosenergoatom Concern JSC:企業の戦略的SWOT分析
    Rosenergoatom Concern JSC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • TUI AG (TUI1):企業の財務・戦略的SWOT分析
    TUI AG (TUI1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Applied Industrial Technologies, Inc.:企業の戦略・SWOT・財務情報
    Applied Industrial Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Applied Industrial Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Calamos Asset Management, Inc.:企業の戦略・SWOT・財務分析
    Calamos Asset Management, Inc. - Strategy, SWOT and Corporate Finance Report Summary Calamos Asset Management, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Novotech (Australia) Pty Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Novotech (Australia) Pty Ltd (Novotech) is a contract research organization that offers clinical development services. The organization’s services include clinical trials, data management, biostatistics analysis, audits, regulatory affairs, medical writing, site management and commercializat …
  • Ineos Group AG:企業の戦略的SWOT分析
    Ineos Group AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆